Also listed on Delphi Genetics S.A., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Oct 18, 2031 · High confidence
20-year base term ends Oct 18, 2031
Held by R.P. Scherer Technologies, LLC
Filed Jan 5, 2016 as application 14/988,595 · Granted Nov 27, 2018
Base term, 20 years from filing
Today
2011
2031
Clock starts
Oct 18, 2011
Oct 18, 2011
Term ends
Oct 18, 2031
Oct 18, 2031
Granted
Nov 27, 2018
Nov 27, 2018
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,234,042, to Oct 18, 2031. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 18, 2011, when application 13/275,845, the earliest non-provisional in its chain, was filed (this one was filed Jan 5, 2016) | Oct 18, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,234,042) | resolves to Oct 18, 2031, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 18, 2031 | High confidence |
This family
| US 9,234,042 | In force Oct 2032 | Oct 2032 |
| US 10,138,289 | this patent Oct 2031 | Oct 2031 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 4, 2017 Reel 40844, frame 526 | Nizet, Yannick; Vanderplasschen, Alain; Gillet, Laurent | Delphi Genetics S.A. | Assignment of Assignor's Interest |
| Jun 25, 2021 Reel 56673, frame 745 | Delphi Genetics | R.P. Scherer Technologies, LLC | Assignment of Assignor's Interest |
| Dec 19, 2024 Reel 69743, frame 458 | Catalent CTS (Kansas City), LLC; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Wellness, LLC; Catalent Pharma Solutions, Inc.; Catalent Wellness New Jersey, LLC; Catalent Maryland, Inc.; Catalent Greenville, Inc.; Catalent Micron Technologies, Inc.; Catalent San Diego, Inc.; Catalent Wellness Virginia, LLC; Catalent USA Packaging, LLC; Catalent Pharma Solutions, LLC | Ares Capital Corporation, As Collateral Agent | Security Interest |
| Aug 13, 2026 Reel 76171, frame 543 | Ares Capital Corporation, As Collateral Agent | Catalent CTS (Kansas City), LLC; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, LLC; Catalent Wellness, LLC; Catalent Pharma Solutions, Inc.; Catalent Wellness New Jersey, LLC; Catalent Maryland, Inc.; Catalent Greenville, Inc.; Catalent Micron Technologies, Inc.; Catalent San Diego, Inc.; Catalent Wellness Virginia, LLC; Catalent USA Packaging, LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent CTS (Kansas City), LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Redwood Bioscience, Inc. | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | R.P. Scherer Technologies, LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Pharma Solutions, LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Wellness, LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Pharma Solutions, Inc. | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Wellness New Jersey, LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Maryland, Inc. | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Greenville, Inc. | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Micron Technologies, Inc. | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent San Diego, Inc. | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent Wellness Virginia, LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
| Aug 13, 2026 reel/frame not recorded | Ares Capital Corporation, As Collateral Agent | Catalent USA Packaging, LLC | Release of Security Interest in Intellectual Property (PATENTS) at Reel 069743, Frame 0458 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2031
Term ends Oct 18, 2031. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,234,042, ends no earlier than this term, so it caps nothing.
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.